ATIN — Athanase Innovation AB Balance Sheet
0.000.00%
- SEK272.10m
- SEK16.61m
- SEK115.27m
Annual balance sheet for Athanase Innovation AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 June 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14.9 | 747 | 644 | 457 | 311 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.3 | 3.97 | 6.47 | 7.84 | 14.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 22.3 | 755 | 662 | 502 | 344 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.243 | 1 | 0.861 | 2.05 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 677 | 919 | 827 | 683 | 552 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15.8 | 10.7 | 34.8 | 48.8 | 67.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 433 | 11.3 | 35.4 | 49.1 | 67.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 244 | 907 | 792 | 634 | 485 |
| Total Liabilities & Shareholders' Equity | 677 | 919 | 827 | 683 | 552 |
| Total Common Shares Outstanding |